Tags: Rexceptor

announcements

Research Foundations Collaborate to Fund Ph 1 Study of Cancer Drug In Alzheimer's Disease Patients

The ADDF and BrightFocus Foundation announced a funding collaboration to support a Phase I clinical trial to evaluate the cancer drug bexarotene as a treatment for Alzheimer's.